Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
The divestment follows Morrow Bank’s announcement on 8 June 2026 regarding strategic options for certain non-core assets following the acquisition of MedMera. In a separate transaction, Morrow Bank has also agreed to sell its Norwegian and Finnish NPL portfolios. The portfolios amounted to approximately SEK 1.5 billion as per 31 August 2026. The transactions simplify operations, accelerate the integration of MedMera and strengthen the focus on profitable growth.
Vinge’s team primarily consisted of Samra Tesser, Viktor Ramhult, Mana Sohrabi and Ebba Dahlberg (M&A), Emma Stuart-Beck, Elias Bohlin and Rebecka Björnestedt (Financial Services), Eva Fredrikson, Mario Saad and Katja Häglund (Commercial Contracts & IT), Sam Seddigh and Louisa Fagarsan (Employment), Axel Lennartsson (IP) and Cecilia Loctander (Senior Transaction Support Co-ordinator).
The transactions are subject to customary regulatory approvals and are expected to be completed before year-end 2026.
For details of the transaction, please refer to Morrow Bank’s press release.
